<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051985</url>
  </required_header>
  <id_info>
    <org_study_id>CEC 877</org_study_id>
    <nct_id>NCT02051985</nct_id>
  </id_info>
  <brief_title>Early-start Exercise Training in Subacute Heart Failure</brief_title>
  <acronym>RE-START</acronym>
  <official_title>Early-start Exercise Training After Acute Hemodynamic Decompensation in Patients With Chronic Heart Failure. A Multicenter, Randomized, Controlled Trial on Feasibility and Impact on Functional Capacity, Symptoms and Neurohumoral Activation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Salvatore Maugeri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Salvatore Maugeri</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the feasibility and the short-term effects of an
      early-start aerobic exercise training program on functional capacity, symptoms and
      neurohormonal activation in chronic heart failure patients with recent acute hemodynamic
      decompensation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prescription of aerobic exercise training in stable chronic heart failure patients finds an
      evidence-based justification in the acknowledged long-term positive effects of aerobic
      exercise training on both functional capacity and prognosis in this population. In recent
      time, evidence has accumulated in normal subjects about short-term favorable effects of
      aerobic exercise training on sympatho-vagal balance and flow-mediated vasodilation, two
      physiological mechanisms known to be profoundly altered in the setting of acute hemodynamic
      decompensation of chronic heart failure. The possible extension of aerobic exercise training
      indication to chronic heart failure patients admitted for recent acute hemodynamic
      decompensation not stabilized as yet, may thus provide a valuable, low-cost tool to
      effectively manage such a high-risk and resource-absorbing population.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance walked at 6-min walking test</measure>
    <time_frame>12 days of intervention</time_frame>
    <description>Change from baseline in distance walked at 6-min walking test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aerobic exercise training safety and tolerability</measure>
    <time_frame>12 days of treatment</time_frame>
    <description>Number of participants with serious/non-serious adverse events and completing/not completing the study protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported dyspnea, evaluated by a 7-point Likert scale</measure>
    <time_frame>12 days of intervention</time_frame>
    <description>Change from baseline in patient-reported dyspnea on a 7-point Likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of lymphocyte G protein-coupled receptor kinase-2</measure>
    <time_frame>12 days of intervention</time_frame>
    <description>Change from baseline in lymphocyte G protein-coupled receptor kinase-2 levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of circulating inflammatory and angiogenetic markers (TNF-alfa, Interleukin-6, Angiopoietin 2 and VEGF)</measure>
    <time_frame>12 days of intervention</time_frame>
    <description>Change from baseline in circulating inflammatory and angiogenetic markers (TNF-alfa, Interleukin-6, Angiopoietin 2 and VEGF) levels</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Chronic Heart Failure</condition>
  <condition>Heart Decompensation</condition>
  <arm_group>
    <arm_group_label>Aerobic exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard physical therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic exercise training</intervention_name>
    <description>Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration).
Days 3-4: as days 1-2 + unloaded bedside cycle ergometer (3 sessions/day, each 5-6 minutes duration).
Days 5-6: as days 1-2 + bedside cycle ergometer at 10 W (3 sessions/day, each 15-20 minutes duration).
Days 7-12: as days 1-2 + bedside cycle ergometer at 10-20 W (3 sessions/day, each 15-20 minutes duration).
In addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.</description>
    <arm_group_label>Aerobic exercise training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard physical therapy</intervention_name>
    <description>Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration).
Days 3-12: active assisted mobilization (1 session/day, 30 minutes duration).
In addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.</description>
    <arm_group_label>Standard physical therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history of chronic heart failure for at least 6 months, with ongoing acute
             decompensation defined as onset or worsening of heart failure signs and/or symptoms
             during the previous 15 days with need of intravenous diuretic and/or vasodilator
             therapy;

          -  age &gt;18 years

          -  left ventricular ejection fraction &lt;40%

          -  proBNP &gt;1000 pg/ml at admission

        Exclusion Criteria:

          -  ongoing cardiogenic shock

          -  need of intravenous inotropic therapy

          -  acute coronary syndrome during the preceding 3 months

          -  clinical and/or instrumental evidence of myocardial ischemia and/or life-threatening
             arrhythmias

          -  previous cardiac valve surgery

          -  creatinine &gt;2.5 mg/dl at admission

          -  severe comorbidities limiting functional capacity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pantaleo Giannuzzi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Fondazione Salvatore Maugeri - Scientific Institute of Veruno</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alessandro Mezzani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Salvatore Maugeri - Scientific Institute of Veruno</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandro Mezzani, MD</last_name>
    <phone>+39-3403119299</phone>
    <email>alessandro.mezzani@fsm.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pantaleo Giannuzzi, MD</last_name>
    <phone>+39-0322-884812</phone>
    <email>pantaleo.giannuzzi@fsm.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Cassano Murge</name>
      <address>
        <city>Cassano Murge</city>
        <zip>70020</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaella Catanzaro, MD</last_name>
      <email>raffaella.catanzaro@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Raffaella Catanzaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Lumezzane</name>
      <address>
        <city>Lumezzane</city>
        <zip>25066</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Rivadossi, MD</last_name>
      <email>francesca.rivadossi@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Francesca Rivadossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri - Scientific Institute of Milano</name>
      <address>
        <city>Milano</city>
        <zip>20138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Totaro, MD</last_name>
      <email>paolo.totaro@fsm.it</email>
    </contact>
    <contact_backup>
      <last_name>, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Paolo Totaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mauro Monelli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Montescano</name>
      <address>
        <city>Montescano</city>
        <zip>27040</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Egidio Traversi, MD</last_name>
      <email>egidio.traversi@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Egidio Traversi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Pavia</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Gualco, MD</last_name>
      <email>alessandra.gualco@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Alessandra Gualco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Telese Terme</name>
      <address>
        <city>Telese Terme</city>
        <zip>82037</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Cacciatore, MD</last_name>
      <email>francesco.cacciatore@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Cacciatore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri - Presidio Major of Torino</name>
      <address>
        <city>Torino</city>
        <zip>10124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Franco Tarrogenta, MD</last_name>
      <email>franco.tarrogenta@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Franco Tarrogenta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Tradate</name>
      <address>
        <city>Tradate</city>
        <zip>21049</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniela Guzzetti, MD</last_name>
      <email>daniela.guzzetti@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Daniela Guzzetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Veruno</name>
      <address>
        <city>Veruno</city>
        <zip>28010</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Mezzani, MD</last_name>
      <phone>3403119299</phone>
      <email>alessandro.mezzani@fsm.it</email>
    </contact>
    <investigator>
      <last_name>Alessandro Mezzani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.fsm.it</url>
  </link>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <last_update_submitted>January 29, 2014</last_update_submitted>
  <last_update_submitted_qc>January 29, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Salvatore Maugeri</investigator_affiliation>
    <investigator_full_name>Alessandro Mezzani</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Chronic heart failure</keyword>
  <keyword>Heart decompensation</keyword>
  <keyword>Aerobic exercise training</keyword>
  <keyword>Functional capacity</keyword>
  <keyword>Dyspnea</keyword>
  <keyword>Beta-adrenergic receptor signaling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

